Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss in Discoid Lupus.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Depression worsens eczema severity, increases inflammation, and lowers quality of life.

Female pattern hair loss greatly lowers quality of life, especially in young women.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Hirsutism greatly lowers the quality of life for Turkish women.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

Hirsutism significantly lowers the quality of life for Turkish women.

Mesenchymal stem cell proteins in a special gel improved healing of severe burns.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Tet2 and Tet3 enzymes are important for controlling hair growth and shape by affecting gene activity and DNA structure in hair follicles.

The research mapped gene activity in developing mouse skin and found key markers for skin cell types and changes from fetal to early postnatal stages.

Key skin cell regulators and gene organization changes are crucial for skin cell development and could help treat skin disorders.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Tet2 and Tet3 enzymes are essential for controlling hair growth by affecting DNA demethylation and gene expression in mice.

Scalp lesions in discoid lupus are more common in women and linked to other autoimmune diseases.